Loading...

Evoke Pharma, Inc.

EVOKNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$6.06
$-0.93(-13.30%)

Evoke Pharma, Inc. (EVOK) Company Profile & Overview

Explore Evoke Pharma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Evoke Pharma, Inc. (EVOK) Company Profile & Overview

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMatthew J. D'Onofrio MBA

Contact Information

858 345 1494
420 Stevens Avenue, Solana Beach, CA, 92075

Company Facts

3 Employees
IPO DateSep 25, 2013
CountryUS
Actively Trading

Frequently Asked Questions

;